Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.

Also called NCT02424500

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 181 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02424500
Other papers using this trial's data
  • Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial Lancet (London, England), 2019-03-16 DOI, PubMed 30808512, PMC6715130 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02424500. Randomized; no masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2017-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Condition
Diabetes Mellitus, Type 2
Condition
Hypoglycemia
Intervention (Device)
d-Nav
Intervention (Device)
Blood Glucose Monitoring System
Lead sponsor
Hygieia Research LLC (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02424500
Content hash
b9144382633f6bb037d36689a0c05d80647a245e8c8040f5881e116683647e37